Research Articles | Page 2 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia Mar 2025 Blood Cancer Journal Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
EPYSQLI (SB12; Biosimilar to Reference Eculizumab) in Asian and Non-Asian Patients With Paroxysmal Nocturnal Hemoglobinuria: Subgroup Analysis of a Global Phase III Randomized Controlled Trial Mar 2025 eJHaem Paroxysmal Nocturnal Hemoglobinuria (PNH)
EPYSQLI (SB12; Biosimilar to Reference Eculizumab) in Asian and Non-Asian Patients With Paroxysmal Nocturnal Hemoglobinuria: Subgroup Analysis of a Global Phase III Randomized Controlled Trial Mar 2025 EJHaem Paroxysmal Nocturnal Hemoglobinuria (PNH)
Heterogeneity in Health-Related Quality of Life of Patients with Aplastic Anemia: A Latent Profile Analysis Mar 2025 Patient Preference and Adherence Aplastic Anemia
Advancing drug development in myelodysplastic syndromes Mar 2025 Blood Advances Myelodysplastic Syndromes (MDS)
Standardization of Bone Marrow Reporting for Myelodysplastic Syndromes/Neoplasms on Behalf of the International Consortium for Myelodysplastic Syndromes/Neoplasms Mar 2025 Archives of Pathology & Laboratory Medicine Myelodysplastic Syndromes (MDS)
STAT signaling in the pathogenesis and therapy of acute myeloid leukemia and myelodysplastic syndromes Mar 2025 Neoplasia Myelodysplastic Syndromes (MDS)
Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates Feb 2025 Blood Advances Aplastic Anemia
Thrombosis at Unusual Sites: Focus on Myeloproliferative Neoplasms and Paroxysmal Nocturnal Hemoglobinuria Feb 2025 Hamostaseologie Myeloproliferative Neoplasms (MPN), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Treatment of lower-risk myelodysplastic syndromes Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)